All News

10-Year-Old Child With Cancer Sworn in as Honorary Member of NYPD, Experts Suggest a New Name for Certain Prostate Cancers and More

April 22nd 2022

From Philadelphia Flyers’ employees suing the organization after developing a rare blood cancer to experts proposing a new name for low-risk prostate cancer and an actor on Disney+’s “The Mandolorian” dying of cancer, here’s what is happening in the cancer space this week.

Educated Patient® Kidney Cancer Summit Surgical Options Presentation: April 9, 2022

April 22nd 2022

Watch Dr. Jose Karam, from The University of Texas MD Anderson Cancer Center, discuss surgical options, during the CURE Educated Patient Kidney Cancer Summit.

Certain Blood Cancer Treatments Pulled from US Market After Treatment Results Fail to Show Improved Survival

April 21st 2022

The pharmaceutical company developing a combination regimen of ublituximab plus Ukoniq (known as U2) pulled the drug duo’s indications for the treatment of multiple types of blood cancer after clinical trial results fell short of improving overall survival.

Post-Chemo Fatigue is Nothing Like Your Typical Tiredness, It Can Stop You Dead in Your Tracks

April 21st 2022

I can’t plan anything without planning time to rest. I literally have to schedule my whole day around when I can lie down to nap.

Cancer and COVID-19 Have Taxed My Imagination

April 21st 2022

As the COVID-19 pandemic seems to be winding down, I’ll still be masking up, knowing that it could return as quickly as it left.

How Can Patients With Cancer, Caregivers Find the Best Mental Health Care Available?

April 21st 2022

Experts from Cancer Treatment Centers of America explain why mental health is important from cancer diagnosis through survivorship, the types of therapy and more.

Educated Patient® Kidney Cancer Summit Diagnosis Panel: April 9, 2022

April 21st 2022

Watch Dr. Vitaly Margulis, Dr. Rana Mckay and Kwame Garrett-Price answer questions about kidney cancer diagnoses during the CURE Educated Patient Kidney Cancer Summit.

Novel Drug Elicits High Response Rates in Relapsed/Refractory Lymphoma Subset

April 20th 2022

Findings from an early-phase clinical trial show that treatment with epcoritamab led to a 63.1% response rate in patients with pretreated large B-cell lymphoma.

Certain Blood Types Associated With Increased Blood Clotting Risk in Patients With Cancer

April 20th 2022

An expert noted that despite the results, all patients with cancer should be aware of their increased risk for developing blood clots.

The Trauma From My Cancer Journey Has Adequately Prepared Me for Crossroads Life Throws My Way

April 20th 2022

My wife and I took a weekend break from the worries of cancer and everyday life, but things did not go as planned, forcing me to tap into all the self-work I’ve been focusing on this year.

How a Standardized Staging System Helps Patients, Providers Choose Best Kidney Cancer Treatment Options

April 20th 2022

By understanding what a TNM staging score is, patients and clinicians can determine the best line of treatment for their kidney cancer, as well as what the survivorship care plan should be.

Educated Patient® Kidney Cancer Summit Genetic Testing in RCC Presentation: April 9, 2022

April 20th 2022

Watch Dr. Rana R. McKay, from the University of California San Diego, discuss genetic testing in renal cell carcinoma during the CURE Educated Patient Kidney Cancer Summit.

Clinical Trials Come to a ‘Disappointing’ End When Drug Combo Fails to Improve Outcomes in Kidney and Bladder Cancer

April 19th 2022

The clinical development of BEMPEG plus Opdivo will end after clinical trials showed that the drug combination did not lead to significant improvements in outcomes in patients with kidney or bladder cancer.

Less Surgery Shown to Preserve Better Long-Term Quality of Life in Patients With Early-Stage Breast Cancer

April 19th 2022

Patients with early-stage breast cancer are advised to ask their provider what the least invasive treatment option is available to them that gives them both a great cure rate and a much better quality of life.

Patients With Cancer Don't Owe 'Grief Tourists' Anything

April 19th 2022

After going public with my cancer diagnosis, I was met with an onslaught of “grief tourists” who may not have been interested in the harsh realities of cancer.

Skin Cancer Diagnosis, Older Age May Be Associated With Increased Risk for Rare Skin Condition from Immunotherapy Treatment

April 19th 2022

Patients within the study who developed the rare skin condition were more likely to experience better tumor responses than those who did not develop the side effect.

Educated Patient® Kidney Cancer Summit Staging Presentation: April 9, 2022

April 19th 2022

Watch Dr. Vitaly Margulis, from UT Southwestern Medical Center, discuss staging, during the CURE Educated Patient Kidney Cancer Summit.

Healthy Pregnancy Is ‘Definitely’ Possible for Women With MPNs

April 18th 2022

Patients with myeloproliferative neoplasms, a group of blood cancers, who plan to conceive should talk with their doctor about their obstetric and medical history and risk of complications, according to an expert.

Navigating the End of Life Does Not Have to Be a Solitary Journey

April 18th 2022

An expert discusses the resources and support available to people to better face their end-of-life journey.

Hoping For a Miracle: Mental Health Care Should Be Standard Treatment for All Cancers

April 18th 2022

A trauma therapist who specializes in cancer would have been helpful for my wife and I as we navigated her cancer experience, but the option was never discussed at our health care visits.

A Step Forward in Treating KRAS G12-Mutated Lung Cancer

April 18th 2022

Activating mutations in this class of oncogenes, specifically KRAS, have made a big step forward scientifically and clinically just in the last couple of years.

Early-Phase Trial to Investigate Novel CAR-T Cell Therapy Alongside Oncolytic Virus in Recurrent Brain Cancer Set to Launch

April 18th 2022

The plan to launch the phase 1 trial to evaluate the safety and efficacy of combining the CAR-T cell therapy and oncolytic virus in patients with recurrent glioblastoma, a type of brain cancer, is supported by interim data from two ongoing trials.

I Have Some Regrets Around How I Handled My Wife’s Cancer

April 17th 2022

Upon reflecting on my late wife's cancer experience, one of my major regrets is not properly saying goodbye.

Treatment Advancements in Lung Cancer Lead to ‘Tremendous Growth’

April 16th 2022

Recent advancements surrounding the development of biomarker- targeted therapies have revolutionized the treatment of lung cancer.

Pharma Company Stops Patient Enrollment in Ewing Sarcoma Trial to Prioritize Development of a Blood Cancer Drug

April 15th 2022

The plan, according to the San Diego-based pharmaceutical company, is to launch a phase 3 trial to analyze the safety and efficacy of a novel drug in mantle cell lymphoma in the second half of 2022.

Trial to Evaluate Safety, Efficacy of Novel Drug for Various Solid Tumors Treats First Patient

April 15th 2022

The primary focus of the trial is to evaluate the incidence of treatment-emergent and serious side effects in patients receiving either the novel drug alone or in combination with Keytruda.

A Metastatic Breast Cancer Conference Helped Me Connect With Hope

April 15th 2022

When I was first diagnosed with metastatic breast cancer, I did not know there were so many other people like me until I attended Living Beyond Breast Cancer’s Conference on Metastatic Breast Cancer.

Netflix Star Reveals Cancer Diagnosis, ‘Good Morning America’ Host Robin Roberts Discusses Emotions Surrounding Partner’s Cancer Journey and More

April 15th 2022

From a Netflix star revealing a breast cancer diagnosis to “Good Morning America” host Robin Roberts sharing what emotions she felt when partner Amber Laign was diagnosed with breast cancer, here’s what is happening in the cancer space this week.

Opdivo-Yervoy Combo Induces Survival Benefit in Advanced Skin Cancer

April 14th 2022

Compared with Yervoy alone, the use of Yervoy plus Opdivo was associated with a significant survival benefit as a second-line treatment in patients with previously treated advanced melanoma, a type of skin cancer.

What Patients With Lung Cancer Don’t Know May Be Critically Important

April 14th 2022

Patients who are part of an advocacy group may be better equipped to understand biomarker testing during a lung cancer diagnosis and feel more empowered.